GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Virus-induced-signaling adapter) (VISA)

 MAVS_MOUSE              Reviewed;         503 AA.
Q8VCF0;
08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
01-MAR-2002, sequence version 1.
17-JUN-2020, entry version 157.
RecName: Full=Mitochondrial antiviral-signaling protein {ECO:0000305};
Short=MAVS {ECO:0000305};
AltName: Full=CARD adapter inducing interferon beta;
Short=Cardif;
AltName: Full=Interferon beta promoter stimulator protein 1;
Short=IPS-1 {ECO:0000303|PubMed:24037184};
AltName: Full=Virus-induced-signaling adapter;
Short=VISA {ECO:0000303|PubMed:24037184};
Name=Mavs {ECO:0000312|MGI:MGI:2444773};
Synonyms=Ips1 {ECO:0000303|PubMed:24037184},
Visa {ECO:0000303|PubMed:24037184};
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=16125763; DOI=10.1016/j.cell.2005.08.012;
Seth R.B., Sun L., Ea C.-K., Chen Z.J.;
"Identification and characterization of MAVS, a mitochondrial antiviral
signaling protein that activates NF-kappaB and IRF 3.";
Cell 122:669-682(2005).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=16153868; DOI=10.1016/j.molcel.2005.08.014;
Xu L.-G., Wang Y.-Y., Han K.-J., Li L.-Y., Zhai Z., Shu H.-B.;
"VISA is an adapter protein required for virus-triggered IFN-beta
Signaling.";
Mol. Cell 19:727-740(2005).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=16177806; DOI=10.1038/nature04193;
Meylan E., Curran J., Hofmann K., Moradpour D., Binder M.,
Bartenschlager R., Tschopp J.;
"Cardif is an adaptor protein in the RIG-I antiviral pathway and is
targeted by hepatitis C virus.";
Nature 437:1167-1172(2005).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=C57BL/6J; TISSUE=Liver;
PubMed=16141072; DOI=10.1126/science.1112014;
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
"The transcriptional landscape of the mammalian genome.";
Science 309:1559-1563(2005).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=FVB/N; TISSUE=Eye, Liver, and Salivary gland;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project:
the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152 AND SER-384, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=17242355; DOI=10.1073/pnas.0609836104;
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
"Large-scale phosphorylation analysis of mouse liver.";
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
[7]
INTERACTION WITH TRAFD1.
PubMed=18849341; DOI=10.1074/jbc.m806923200;
Sanada T., Takaesu G., Mashima R., Yoshida R., Kobayashi T., Yoshimura A.;
"FLN29 deficiency reveals its negative regulatory role in the Toll-like
receptor (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicase
signaling pathway.";
J. Biol. Chem. 283:33858-33864(2008).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-172 AND SER-384, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, Spleen,
and Testis;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and expression.";
Cell 143:1174-1189(2010).
[9]
INTERACTION WITH SMURF1.
PubMed=23087404; DOI=10.4049/jimmunol.1201445;
Wang Y., Tong X., Ye X.;
"Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing
E3 ligase Smurf1-mediated MAVS degradation.";
J. Immunol. 189:5304-5313(2012).
[10]
FUNCTION, AND INTERACTION WITH DHX33.
PubMed=24037184; DOI=10.1038/cmi.2013.40;
Liu Y., Lu N., Yuan B., Weng L., Wang F., Liu Y.J., Zhang Z.;
"The interaction between the helicase DHX33 and IPS-1 as a novel pathway to
sense double-stranded RNA and RNA viruses in myeloid dendritic cells.";
Cell. Mol. Immunol. 11:49-57(2014).
[11]
METHYLATION [LARGE SCALE ANALYSIS] AT ARG-234, AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brain;
PubMed=24129315; DOI=10.1074/mcp.o113.027870;
Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
Bedford M.T., Comb M.J.;
"Immunoaffinity enrichment and mass spectrometry analysis of protein
methylation.";
Mol. Cell. Proteomics 13:372-387(2014).
-!- FUNCTION: Required for innate immune defense against viruses
(PubMed:24037184). Acts downstream of DHX33, DDX58/RIG-I and
IFIH1/MDA5, which detect intracellular dsRNA produced during viral
replication, to coordinate pathways leading to the activation of NF-
kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral
cytokines such as IFN-beta and RANTES (CCL5) (PubMed:24037184).
Peroxisomal and mitochondrial MAVS act sequentially to create an
antiviral cellular state (By similarity). Upon viral infection,
peroxisomal MAVS induces the rapid interferon-independent expression of
defense factors that provide short-term protection, whereas
mitochondrial MAVS activates an interferon-dependent signaling pathway
with delayed kinetics, which amplifies and stabilizes the antiviral
response (By similarity). May activate the same pathways following
detection of extracellular dsRNA by TLR3 (By similarity). May protect
cells from apoptosis (By similarity). {ECO:0000250|UniProtKB:Q7Z434,
ECO:0000269|PubMed:24037184}.
-!- SUBUNIT: Self-associates and polymerizes (via CARD domains) to form 400
nM long three-stranded helical filaments on mitochondria, filament
nucleation requires interaction with DDX58/RIG-I whose CARD domains act
as a template for filament assembly (By similarity). Interacts with
DDX58/RIG-I, IFIH1/MDA5, TRAF2, TRAF6 and C1QBP (By similarity). May
interact with FADD, RIPK1, IKBKE, CHUK and IKBKB (By similarity).
Interacts (when phosphorylated) with IRF3; following activation and
phosphorylation on the pLxIS motif by TBK1, recruits IRF3 (By
similarity). Interacts with NLRX1 (By similarity). Interaction with
NLRX1 requires the CARD domain (By similarity). Interacts with PSMA7
(By similarity). Interacts with TRAFD1 (PubMed:18849341). Interacts
(via C-terminus) with PCBP2 in a complex containing MAVS/IPS1, PCBP2
and ITCH (By similarity). Interacts with CYLD (By similarity).
Interacts with SRC (By similarity). Interacts with DHX58/LGP2 and IKBKE
(By similarity). Interacts with STING1 (By similarity). Interacts with
IFIT3 (via N-terminus) (By similarity). Interacts with TBK1 only in the
presence of IFIT3 (By similarity). Interacts with TTLL12; the
interaction prevents MAVS binding to TBK1 and IKBKE (By similarity).
Interacts with MUL1 (By similarity). Interacts with ANKRD17 (By
similarity). Interacts with NDFIP1 (By similarity). Interacts with
SMURF1; the interaction is mediated by NDFIP1 and leads to MAVS
ubiquitination and degradation (PubMed:23087404). Interacts (via C-
terminus) with GPATCH3; the interaction is markedly increased upon
viral infection (By similarity). Directly interacts (via CARD domain)
with ATG5 and ATG12, either as ATG5 and ATG12 monomers or as ATG12-ATG5
conjugates (By similarity). Interacts with DHX33 (via the helicase C-
terminal domain) (PubMed:24037184). Interacts with DDX3X (via C-
terminus); this interaction may occur rapidly, but transiently after
viral infection (By similarity). The interaction with DDX3X potentiates
MAVS-mediated IFNB induction (By similarity). Conversely inhibition of
this interaction prevents MAVS-mediated IFNB induction (By similarity).
Transiently interacts with TRAF3 early during viral infection (By
similarity). {ECO:0000250|UniProtKB:Q7Z434,
ECO:0000269|PubMed:18849341, ECO:0000269|PubMed:23087404,
ECO:0000269|PubMed:24037184}.
-!- INTERACTION:
Q8VCF0; Q60803: Traf3; NbExp=4; IntAct=EBI-3862816, EBI-520135;
-!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
{ECO:0000250|UniProtKB:Q7Z434}. Mitochondrion
{ECO:0000250|UniProtKB:Q7Z434}. Peroxisome
{ECO:0000250|UniProtKB:Q7Z434}.
-!- DOMAIN: Both CARD and transmembrane domains are essential for antiviral
function. The CARD domain is responsible for interaction with
DDX58/RIG-I and IFIH1/MDA5 (By similarity).
{ECO:0000250|UniProtKB:Q7Z434}.
-!- DOMAIN: The transmembrane domain and residues 285-420 are essential for
its interaction with DHX58/LGP2. {ECO:0000250|UniProtKB:Q7Z434}.
-!- DOMAIN: The pLxIS motif constitutes an IRF3-binding motif: following
phosphorylation by TBK1, the phosphorylated pLxIS motif of MAVS
recruits IRF3. IRF3 is then phosphorylated and activated by TBK1 to
induce type-I interferons and other cytokines.
{ECO:0000250|UniProtKB:Q7Z434}.
-!- DOMAIN: Both CARD and transmembrane domains are essential for antiviral
function. The CARD domain is responsible for interaction with
DDX58/RIG-I and IFIH1/MDA5. {ECO:0000250|UniProtKB:Q7Z434}.
-!- DOMAIN: The transmembrane domain and residues 300-444 are essential for
its interaction with DHX58/LGP2. {ECO:0000250|UniProtKB:Q7Z434}.
-!- PTM: Following activation, phosphorylated by TBK1 at Ser-418 in the
pLxIS motif. The phosphorylated pLxIS motif constitutes an IRF3-binding
motif, leading to recruitment of the transcription factor IRF3 to
induce type-I interferons and other cytokines.
{ECO:0000250|UniProtKB:Q7Z434}.
-!- PTM: Ubiquitinated. Undergoes 'Lys-48'-linked polyubiquitination
catalyzed by ITCH; ITCH-dependent polyubiquitination is mediated by the
interaction with PCBP2 and leads to MAVS/IPS1 proteasomal degradation.
Ubiquitinated by RNF125, leading to its degradation by the proteasome.
Undergoes 'Lys-48'-linked ubiquitination catalyzed by SMURF1.
{ECO:0000250|UniProtKB:Q7Z434}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; DQ174271; AAZ80418.1; -; mRNA.
EMBL; DQ167127; ABA54891.1; -; mRNA.
EMBL; AK028421; BAC25940.1; -; mRNA.
EMBL; BC020006; AAH20006.1; -; mRNA.
EMBL; BC025825; AAH25825.1; -; mRNA.
EMBL; BC031352; AAH31352.1; -; mRNA.
EMBL; BC037391; AAH37391.1; -; mRNA.
CCDS; CCDS16760.1; -.
RefSeq; NP_001193314.1; NM_001206385.1.
RefSeq; NP_659137.1; NM_144888.2.
PDB; 4GHU; X-ray; 2.20 A; B=138-158.
PDBsum; 4GHU; -.
SMR; Q8VCF0; -.
BioGRID; 230748; 14.
DIP; DIP-43890N; -.
IntAct; Q8VCF0; 6.
MINT; Q8VCF0; -.
STRING; 10090.ENSMUSP00000105828; -.
iPTMnet; Q8VCF0; -.
PhosphoSitePlus; Q8VCF0; -.
SwissPalm; Q8VCF0; -.
EPD; Q8VCF0; -.
jPOST; Q8VCF0; -.
MaxQB; Q8VCF0; -.
PaxDb; Q8VCF0; -.
PeptideAtlas; Q8VCF0; -.
PRIDE; Q8VCF0; -.
Antibodypedia; 3363; 634 antibodies.
Ensembl; ENSMUST00000041362; ENSMUSP00000038339; ENSMUSG00000037523.
Ensembl; ENSMUST00000110199; ENSMUSP00000105828; ENSMUSG00000037523.
GeneID; 228607; -.
KEGG; mmu:228607; -.
UCSC; uc008mld.2; mouse.
CTD; 57506; -.
MGI; MGI:2444773; Mavs.
eggNOG; ENOG410IS5U; Eukaryota.
eggNOG; ENOG410Y2HK; LUCA.
GeneTree; ENSGT00510000049120; -.
HOGENOM; CLU_042052_0_0_1; -.
InParanoid; Q8VCF0; -.
KO; K12648; -.
OMA; HNGYREE; -.
OrthoDB; 887440at2759; -.
PhylomeDB; Q8VCF0; -.
TreeFam; TF333444; -.
Reactome; R-MMU-936440; Negative regulators of DDX58/IFIH1 signaling.
BioGRID-ORCS; 228607; 1 hit in 12 CRISPR screens.
ChiTaRS; Mavs; mouse.
PRO; PR:Q8VCF0; -.
Proteomes; UP000000589; Chromosome 2.
RNAct; Q8VCF0; protein.
Bgee; ENSMUSG00000037523; Expressed in brown adipose tissue and 260 other tissues.
ExpressionAtlas; Q8VCF0; baseline and differential.
Genevisible; Q8VCF0; MM.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0031966; C:mitochondrial membrane; ISO:MGI.
GO; GO:0005741; C:mitochondrial outer membrane; ISO:MGI.
GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
GO; GO:0005778; C:peroxisomal membrane; ISO:MGI.
GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
GO; GO:0050700; F:CARD domain binding; ISO:MGI.
GO; GO:0019901; F:protein kinase binding; ISO:MGI.
GO; GO:0035591; F:signaling adaptor activity; IMP:UniProtKB.
GO; GO:0002218; P:activation of innate immune response; ISO:MGI.
GO; GO:0071360; P:cellular response to exogenous dsRNA; ISS:UniProtKB.
GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
GO; GO:0051607; P:defense response to virus; ISO:MGI.
GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
GO; GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB.
GO; GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; ISO:MGI.
GO; GO:0002230; P:positive regulation of defense response to virus by host; IMP:MGI.
GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISO:MGI.
GO; GO:0032727; P:positive regulation of interferon-alpha production; ISS:UniProtKB.
GO; GO:1902741; P:positive regulation of interferon-alpha secretion; ISS:UniProtKB.
GO; GO:0032728; P:positive regulation of interferon-beta production; ISS:UniProtKB.
GO; GO:0035549; P:positive regulation of interferon-beta secretion; ISS:UniProtKB.
GO; GO:2000778; P:positive regulation of interleukin-6 secretion; ISS:UniProtKB.
GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:MGI.
GO; GO:0071660; P:positive regulation of IP-10 production; ISO:MGI.
GO; GO:0002735; P:positive regulation of myeloid dendritic cell cytokine production; IMP:UniProtKB.
GO; GO:0042307; P:positive regulation of protein import into nucleus; ISO:MGI.
GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI.
GO; GO:0060760; P:positive regulation of response to cytokine stimulus; ISS:UniProtKB.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:MGI.
GO; GO:1904469; P:positive regulation of tumor necrosis factor secretion; ISS:UniProtKB.
GO; GO:0032481; P:positive regulation of type I interferon production; IMP:MGI.
GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; ISO:MGI.
GO; GO:1900063; P:regulation of peroxisome organization; IMP:UniProtKB.
GO; GO:0039529; P:RIG-I signaling pathway; IGI:MGI.
GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
CDD; cd08811; CARD_IPS1; 1.
InterPro; IPR031964; CARD_dom.
InterPro; IPR042144; CARD_IPS1.
InterPro; IPR026148; Mt_antiviral_sig_pro_met.
PANTHER; PTHR21446:SF6; PTHR21446:SF6; 1.
Pfam; PF16739; CARD_2; 1.
1: Evidence at protein level;
3D-structure; Antiviral defense; Immunity; Innate immunity; Membrane;
Methylation; Mitochondrion; Mitochondrion outer membrane; Peroxisome;
Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
Ubl conjugation.
CHAIN 1..503
/note="Mitochondrial antiviral-signaling protein"
/id="PRO_0000144097"
TOPO_DOM 1..478
/note="Cytoplasmic"
/evidence="ECO:0000305"
TRANSMEM 479..496
/note="Helical"
/evidence="ECO:0000255"
TOPO_DOM 497..503
/note="Mitochondrial intermembrane"
/evidence="ECO:0000305"
DOMAIN 10..77
/note="CARD"
REGION 10..77
/note="Required for interaction with NLRX1"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
REGION 143..147
/note="Interaction with TRAF2"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
REGION 153..158
/note="Interaction with TRAF6 1"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
REGION 337..503
/note="Interaction with DHX33"
/evidence="ECO:0000269|PubMed:24037184"
REGION 431..436
/note="Interaction with TRAF6 2"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOTIF 415..418
/note="pLxIS motif"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 152
/note="Phosphoserine"
/evidence="ECO:0000244|PubMed:17242355,
ECO:0000244|PubMed:21183079"
MOD_RES 157
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 172
/note="Phosphoserine"
/evidence="ECO:0000244|PubMed:21183079"
MOD_RES 186
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 220
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 234
/note="Asymmetric dimethylarginine"
/evidence="ECO:0000244|PubMed:24129315"
MOD_RES 251
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 256
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
MOD_RES 384
/note="Phosphoserine"
/evidence="ECO:0000244|PubMed:17242355,
ECO:0000244|PubMed:21183079"
MOD_RES 418
/note="Phosphoserine; by TBK1"
/evidence="ECO:0000250|UniProtKB:Q7Z434"
SEQUENCE 503 AA; 53399 MW; FE4CA1920772BF3E CRC64;
MTFAEDKTYK YIRDNHSKFC CVDVLEILPY LSCLTASDQD RLRASYRQIG NRDTLWGLFN
NLQRRPGWVE VFIRALQICE LPGLADQVTR VYQSYLPPGT SLRSLEPLQL PDFPAAVSGP
SAFAPGHNIP DHGLRETPSC PKPVQDTQPP ESPVENSEQL LQTNSGAVAR MSGGSLIPSP
NQQALSPQPS REHQEQEPEL GGAHAANVAS VPIATYGPVS PTVSFQPLPR TALRTNLLSG
VTVSALSADT SLSSSSTGSA FAKGAGDQAK AATCFSTTLT NSVTTSSVPS PRLVPVKTMS
SKLPLSSKST AAMTSTVLTN TAPSKLPSNS VYAGTVPSRV PASVAKAPAN TIPPERNSKQ
AKETPEGPAT KVTTGGNQTG PNSSIRSLHS GPEMSKPGVL VSQLDEPFSA CSVDLAISPS
SSLVSEPNHG PEENEYSSFR IQVDESPSAD LLGSPEPLAT QQPQEEEEHC ASSMPWAKWL
GATSALLAVF LAVMLYRSRR LAQ


Related products :

Catalog number Product name Quantity
MD-14-0620 Rabbit Anti-VISA (Virus-induced signaling adapter) MAVS _ CARD_Cardif_IPS-1 100
MD-14-0619 Rabbit Anti-VISA (Virus-induced signaling adapter) Middle region MAVS _ CARD_Cardif_IPS-1 100
DL-VISA-Hu Human Virus Induced Signaling Adapter (VISA) ELISA Kit 96T
I2419 Virus Induced Signaling Adapter (VISA), Human, ELISA Kit 96T
201-20-3284 MAVS{virus-induced signaling adapter}rabbit.pAb 0.2ml
SEC597Hu ELISA Kit for Virus Induced Signaling Adapter (VISA) Homo sapiens (Human) 96T
GWB-8B2290 Virus-induced Signaling Adapter (VISA) Rabbit anti-Human Polyclonal (Internal) Antibody
GWB-684F71 Virus-induced Signaling Adapter (VISA) Rabbit anti-Human Polyclonal (N-Terminus) Antibody
orb25671 VISA, N-term antibody Polyclonal VISA (Virus-induced signaling adapter) MAVS_CARD_Cardif_IPS-1 is a rabbit polyclonal antibody to apoptosis and signal transduction reagent. 100
EIAAB38519 Mouse,Mus musculus,SHP2-interacting transmembrane adapter protein,Signaling threshold-regulating transmembrane adapter 1,Sit,Sit1,Suppression-inducing transmembrane adapter 1
EIAAB38520 Rat,Rattus norvegicus,SHP2-interacting transmembrane adapter protein,Signaling threshold-regulating transmembrane adapter 1,Sit,Sit1,Suppression-inducing transmembrane adapter 1
EIAAB38518 gp30_40,Homo sapiens,Human,SHP2-interacting transmembrane adapter protein,Signaling threshold-regulating transmembrane adapter 1,SIT,SIT1,Suppression-inducing transmembrane adapter 1
MAZ MAVS Gene mitochondrial antiviral signaling protein
CSB-EL013526RA Rat Mitochondrial antiviral-signaling protein(MAVS) ELISA kit 96T
orb25672 VISA (Middle) antibody Polyclonal VISA (Virus-induced signaling adapter) Middle region MAVS_CARD_Cardif_IPS-1 is a rabbit polyclonal antibody to apoptosis and signal transduction reagent. 100
CSB-EL013526MO Mouse Mitochondrial antiviral-signaling protein(MAVS) ELISA kit 96T
CSB-EL013526RA Rat Mitochondrial antiviral-signaling protein(MAVS) ELISA kit SpeciesRat 96T
CSB-EL013526HU Human Mitochondrial antiviral-signaling protein(MAVS) ELISA kit 96T
CSB-EL013526MO Mouse Mitochondrial antiviral-signaling protein(MAVS) ELISA kit SpeciesMouse 96T
CSB-EL013526HU Human Mitochondrial antiviral-signaling protein(MAVS) ELISA kit SpeciesHuman 96T
EIAAB41675 Bos taurus,Bovine,TICAM1,TICAM-1,TIR domain-containing adapter molecule 1,TIR domain-containing adapter protein inducing IFN-beta,Toll-interleukin-1 receptor domain-containing adapter protein inducing
MAVS_MOUSE ELISA Kit FOR Mitochondrial antiviral-signaling protein; organism: Mouse; gene name: Mavs 96T
CSB-EL013526RA Rat mitochondrial antiviral signaling protein (MAVS) ELISA kit, Species Rat, Sample Type serum, plasma 96T
EIAAB41674 Mouse,Mus musculus,Ticam1,TICAM-1,TIR domain-containing adapter molecule 1,TIR domain-containing adapter protein inducing IFN-beta,Toll-interleukin-1 receptor domain-containing adapter protein inducin
4053 (NT) Virus-induced signaling adapter 0.5 mg
Pathways :
WP1835: Interferon alpha/beta signaling
WP1136: Type II interferon signaling (IFNG)
WP2218: sGC
WP1371: G Protein Signaling Pathways
WP1836: Interferon gamma signaling
WP35: G Protein Signaling Pathways
WP1049: G Protein Signaling Pathways
WP813: G Protein Signaling Pathways
WP1566: Citrate cycle (TCA cycle)
WP505: TGF Beta Signaling Pathway
WP786: Type II interferon signaling (IFNG)
WP2272: Pathogenic Escherichia coli infection
WP1434: Osteopontin Signaling
WP230: TGF Beta Signaling Pathway
WP1224: EBV LMP1 signaling
WP1367: TGF-beta Receptor Signaling Pathway
WP1165: G Protein Signaling Pathways
WP232: G Protein Signaling Pathways
WP1289: Type II interferon signaling (IFNG)
WP1370: TGF Beta Signaling Pathway
WP1045: TGF-beta Receptor Signaling Pathway
WP809: TGF-beta Receptor Signaling Pathway
WP2203: TSLP Signaling Pathway
WP560: TGF Beta Signaling Pathway
WP1048: TGF Beta Signaling Pathway

Related Genes :
[MAVS IPS1 KIAA1271 VISA] Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA)
[Mavs Ips1 Visa] Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Virus-induced-signaling adapter) (VISA)
[Mavs Ips1 Visa] Mitochondrial antiviral-signaling protein (MAVS) (Interferon beta promoter stimulator protein 1) (IPS-1) (Virus-induced-signaling adapter) (VISA)
[IFIH1 MDA5 RH116] Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116)
[TICAM1 PRVTIRB TRIF] TIR domain-containing adapter molecule 1 (TICAM-1) (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (MyD88-3) (TIR domain-containing adapter protein inducing IFN-beta)
[Ticam1 Trif] TIR domain-containing adapter molecule 1 (TICAM-1) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (TIR domain-containing adapter protein inducing IFN-beta)
[STING1 ERIS MITA TMEM173] Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173)
[Sting1 Eris Mita Mpys Tmem173] Stimulator of interferon genes protein (mSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (MMITA) (Transmembrane protein 173)
[DDX58] Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)
[Ifih1] Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Helicase with 2 CARD domains) (Helicard) (Interferon induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (RIG-I-like receptor 2) (RLR-2)
[STING1 TMEM173] Stimulator of interferon genes protein (poSTING) (Transmembrane protein 173)
[Sting1 Tmem173] Stimulator of interferon genes protein (rSTING) (Transmembrane protein 173)
[STING1 TMEM173] Stimulator of interferon genes protein (STING) (Transmembrane protein 173)
[IFI27] Interferon alpha-inducible protein 27, mitochondrial (p27) (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein) (ISG12(a)) (ISG12A)
[IKBKB IKKB] Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB)
[EIF2AK2 PKR PRKR] Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)
[MX1] Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed]
[Eif2ak2 Pkr Prkr Tik] Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)
[IFIT1 G10P1 IFI56 IFNAI1 ISG56] Interferon-induced protein with tetratricopeptide repeats 1 (IFIT-1) (Interferon-induced 56 kDa protein) (IFI-56K) (P56)
[IRF3] Interferon regulatory factor 3 (IRF-3)
[IKBKE IKKE IKKI KIAA0151] Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)
[rep 1a-1b] Replicase polyprotein 1ab (ORF1ab polyprotein) [Cleaved into: Nsp1 (EC 3.4.22.-); Nsp1-alpha papain-like cysteine proteinase (EC 3.4.22.-) (PCP1-alpha); Nsp1-beta papain-like cysteine proteinase (EC 3.4.22.-) (PCP1-beta); Nsp2 cysteine proteinase (EC 3.4.19.12) (EC 3.4.22.-) (CP2) (CP); Non-structural protein 3 (Nsp3); Serine protease nsp4 (3CLSP) (EC 3.4.21.-) (3C-like serine proteinase) (Nsp4); Non-structural protein 5-6-7 (Nsp5-6-7); Non-structural protein 5 (Nsp5); Non-structural protein 6 (Nsp6); Non-structural protein 7-alpha (Nsp7-alpha); Non-structural protein 7-beta (Nsp7-beta); Non-structural protein 8 (Nsp8); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (Nsp9); Helicase nsp10 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (Nsp10); Non-structural protein 11 (Nsp11); Non-structural protein 12 (Nsp12)]
[sting1 tmem173] Stimulator of interferon genes protein (STING) (Transmembrane protein 173)
[RSAD2 CIG5] Radical S-adenosyl methionine domain-containing protein 2 (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)
[ISG15 G1P2 UCRP] Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP)
[PYCARD ASC CARD5 TMS1] Apoptosis-associated speck-like protein containing a CARD (hASC) (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1)
[TRAF6 RNF85] TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6)
[FADD MORT1 GIG3] FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity) (Protein FADD)
[Eif2ak2 Prkr] Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2)
[Isg15 G1p2 Ucrp] Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein)

Bibliography :
No related Items